Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma
Gong Chen(Guangdong Pharmaceutical University), Mingzhi Zhang(Chinese Academy of Sciences), Zhuangzhuang Shi(First Affiliated Hospital of Zhengzhou University), Jiazhuo Wu(Zhengzhou University), Wenting Song(Huazhong Agricultural University), Hongwen Li(Anhui Medical University), Cunzhen Shi(First Affiliated Hospital of Zhengzhou University), Yuyang Gao(Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University)
Cited by 3
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Photoredox-mediated remote C(sp<sup>3</sup>)–H heteroarylation of free alcohols
|Chemical Science|2018|148
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134